REQUEST A DEMO
Total
USD $0.00
Search more companies

Worldwide Clinical Trials D.O.O. Beograd (Serbia)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Worldwide Clinical Trials D.O.O. Beograd Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Worldwide Clinical Trials D.O.O. Beograd is based in Serbia, with the head office in Belgrade. The enterprise currently operates in the Administrative Management and General Management Consulting Services sector. It was incorporated on October 03, 2005. There are currently 162 (2020) people employed by Worldwide Clinical Trials D.O.O. Beograd. The company’s latest financial report indicates a net sales revenue increase of 57.36% in 2022. Its’ total assets recorded a growth of 24.62%. The enterprise’s net profit margin increased by 1.27% in 2022.

Headquarters
Omladinskih Brigada 90 B
Belgrade; Belgrade; Postal Code: 11000

Contact Details: Purchase the Worldwide Clinical Trials D.O.O. Beograd report to view the information.

Website: http://www.worldwide.com

Basic Information
Total Employees:
Purchase the Worldwide Clinical Trials D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Worldwide Clinical Trials D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Worldwide Clinical Trials D.O.O. Beograd report to view the information.
Incorporation Date:
October 03, 2005
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Worldwide Clinical Trials D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
57.36%
Total operating revenue
55.95%
Operating profit (EBIT)
63.62%
EBITDA
60.83%
Net Profit (Loss) for the Period
86.92%
Total assets
24.62%
Total equity
55.42%
Operating Profit Margin (ROS)
0.41%
Net Profit Margin
1.27%
Return on Equity (ROE)
6.01%
Debt to Equity Ratio
-22.94%
Quick Ratio
0.41%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?